✦ LIBER ✦

342 The role of randomised trials and surrogate biomarkers in early clinical development

✍ Scribed by M. Buyse

Book ID: 119600046
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 42 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(09)70285-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Role of Biomarkers in Cancer Clinica

The Role of Biomarkers in Cancer Clinical Trials

✍ Mary Reid; Joyce Yasko 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Inconsistent reporting of surrogate outc

Inconsistent reporting of surrogate outcomes in randomised clinical trials: cohort study

✍ Jeppe Lerche la Cour, Jesper Brok and Peter C Gøtzsche 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 325 KB

Early-Phase Development of Salivary Proa

Early-Phase Development of Salivary Proangiogenic Cytokines as Biomarkers in Leukoplakia Clinical Trials

✍ Nelson L. Rhodus; Eva Szabo; Beverly Wuertz; Kate Cole; Joe Rohrer; Frank Ondrey 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 76 KB

The Role of Biomarkers in Clinical Trial

The Role of Biomarkers in Clinical Trials for Alzheimer Disease

✍ Thal, Leon J; Kantarci, Kejal; Reiman, Eric M; Klunk, William E; Weiner, Michael 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 306 KB

Clinical trials in children with cancer?

Clinical trials in children with cancer?The problem of early randomisation

✍ Pinkerton, Ross 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

PCN8 OUTCOMES AND COSTS OF SURROGATE END

PCN8 OUTCOMES AND COSTS OF SURROGATE END-POINTS (SES) AND BIOMARKERS IN PHASE I ONCOLOGY CLINICAL TRIALS

✍ BHL Goulart; TG Roberts; Y Liu; JW Clark 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB